Sales and Marketing

Showing 15 posts of 11527 posts found.

Advent reportedly backs out of bid for Pfizer’s Brazil plant

March 23, 2017 Sales and Marketing Brazil, Pfizer, generics

It has been reported that Advent International Corp has pulled out of bidding for Pfizer’s stake in Brazilian generics manufacturer, …

Injectable drug market to grow to $625 billion worldwide by 2021

March 23, 2017 Sales and Marketing injectable drugs, injectables

New data released by intelligence firm MarketsandMarkets indicates that the global injectable drug market is set to reach $625 billion …

Drug prices set to increase on ‘essential medicines’ list in India

March 23, 2017 Sales and Marketing Indian

The annual review of drug prices will see the price of drugs, on the National List of Essential Medicines, increase …

Shire’s drug picked up from Baxalta given fast track designation

March 23, 2017 Research and Development, Sales and Marketing Shire, rare diseases

Shire has announced that its drug, SHP655, has received a fast track designation based on pre-clinical trials and positive results …

FDA approves first Parkinson’s treatment in a decade

March 22, 2017 Research and Development, Sales and Marketing FDA, Parkinson's, Xadago

The FDA has approved Xadago (safinamide) as a supplementary treatment for Parkinson’s in patients currently taking levodopa/carbidopa and who are …

Asia-Pacific NSCLC market to more than double to $6.2bn by 2023

March 21, 2017 Manufacturing and Production, Research and Development, Sales and Marketing BMS, Eli Lilly, MSD, NSCLC, Yervoy, keytruda, opdivo

New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …

Biogaran acquires production foothold in Nigeria with Swipha acquisition

March 21, 2017 Manufacturing and Production, Sales and Marketing Biogaran, Swipharma

Biogaran, the French generic manufacturer that is a subsidiary of Servier, has acquired a foothold in Nigeria with a 95% …

Array BioPharma in disarray over withdrawal of NDA

March 20, 2017 Manufacturing and Production, Sales and Marketing Array Biopharma

Array BioPharma has announced that it has pulled its new drug application (NDA) for its drug, binimetinib, for the treatment …

Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures

March 20, 2017 Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche

Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …

China proposes ways to speed up approval for imported drugs

March 20, 2017 Sales and Marketing China, imported drugs

It can currently take up to three or four years for a new drug to reach market in China, slowing …

Pakistan’s problem with diabetes – with 7 million diabetics

March 20, 2017 Medical Communications, Sales and Marketing Pakistan, Sanofi, diabetes

Pakistan is facing an increasing problem with people suffering from diabetes. At a recent conference, the 4th International Diabetes Conference, …

UK biotech Pulmocide secures $30m for inhalable lung disease therapies

March 20, 2017 Research and Development, Sales and Marketing pulmocide, pulmonary aspergillosis, respiratory syncytial virus

Pulmocide, a UK biotech run by a former GlaxoSmithKline scientists and based in London, has secured $30.4 million in Series …

Pregnancy test pill used through 60s & 70s connected with birth defects

March 20, 2017 Medical Communications, Sales and Marketing Bayer, Primodos

A pregnancy test, named Primodos, which was taken by 1.5 million British mothers and was linked to birth defects, may …

Top Ten most popular articles on Pharmafile.com this week

March 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

As another week comes and goes, waves were sent through the industry as Trump announced his pick as the new …

Ex-Novartis employee found not guilty of deceitful drug advertising

March 17, 2017 Medical Communications, Sales and Marketing Diovan, Novartis, legal

A Tokyo court has ruled finding ex-Novartis employee Nobuo Shirahashi and the company’s Tokyo-based sales arm Novartis Pharma KK not …
The Gateway to Local Adoption Series

Latest content